Elicio Therapeutics Inc.
6.35
0.15 (2.42%)
At close: Jan 15, 2025, 3:43 PM
6.39
0.63%
After-hours Jan 15, 2025, 03:44 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY13 FY12
PE Ratio -1.2 -0.65 -0.71 -3.06 -3.92 -0.87 0.06 0.12
PS Ratio n/a n/a 0.67 16.67 32.28 4.31 0.01 0.00
PB Ratio 3.71 -0.18 -0.25 -0.98 -1.38 0.92 0.02 0.02
P/FCF Ratio -1.29 -0.8 -0.77 -2.84 -4.91 -2.17 0.02 0.04
P/OCF Ratio -1.29 -0.82 -0.79 -2.87 -5.16 -2.17 0.02 0.03
OCF/S Ratio n/a n/a -0.85 -5.8 -6.25 -1.99 0.29 0.15
Debt / Equity Ratio 0.61 -0.07 -0.16 -0.01 -0.02 n/a 2.27 3.18
Quick Ratio 1.67 1.56 0.54 6.07 4.19 3.49 2.28 1.87
Current Ratio 1.67 1.56 0.55 4.67 4.15 3.49 2.28 1.87
Asset Turnover n/a n/a 1.91 0.15 0.17 0.15 0.59 0.66
Interest Coverage -33.75 -6.6 -29.07 n/a n/a n/a -1.32 -1.36
Return on Equity (ROE) -3.09 0.28 0.35 0.32 0.35 -1.06 0.27 0.18
Return on Assets (ROA) -1.3 -1.24 -1.78 -0.8 -1.39 -0.75 0.06 0.03
Return on Capital (ROIC) -2.06 -1.5 6.26 -0.96 -1.74 -0.74 -0.04 -0.04
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a 95.64% 36.88% 23.60% 90.57% 51.78% 49.66%
Net Profit Margin n/a n/a -93.25% -545.56% -824.54% -497.02% 9.61% 4.21%
Pretax Profit Margin n/a n/a -93.25% -545.56% -824.54% -497.02% 26.32% 16.36%
Operating Profit Margin n/a n/a -89.98% -545.87% -830.02% -355.97% -6.04% -5.74%
FCF Margin n/a n/a -86.41% -586.96% -657.94% -199.06% 28.49% 13.94%
EBITDA Margin n/a n/a -183.4% -539.15% -2.70K% -355.92% 0.95% 26.92%